Intracellular Delivery of a Planar DNA Origami Structure by the Transferrin-Receptor Internalization Pathway.

DNA origami provides rapid access to easily functionalized, nanometer-sized structures making it an intriguing platform for the development of defined drug delivery and sensor systems. Low cellular uptake of DNA nanostructures is a major obstacle in the development of DNA-based delivery platforms. Herein, significant strong increase in cellular uptake in an established cancer cell line by modifying a planar DNA origami structure with the iron transport protein transferrin (Tf) is demonstrated. A variable number of Tf molecules are coupled to the origami structure using a DNA-directed, site-selective labeling technique to retain ligand functionality. A combination of confocal fluorescence microscopy and quantitative (qPCR) techniques shows up to 22-fold increased cytoplasmic uptake compared to unmodified structures and with an efficiency that correlates to the number of transferrin molecules on the origami surface.

[1]  Qiao Jiang,et al.  DNA origami as an in vivo drug delivery vehicle for cancer therapy. , 2014, ACS nano.

[2]  P. Low,et al.  Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. , 1994, The Journal of biological chemistry.

[3]  R. Micetich,et al.  Transferrin directed delivery of adriamycin to human cells. , 1998, Anticancer research.

[4]  Björn Högberg,et al.  Spatial control of membrane receptor function using ligand nanocalipers , 2014, Nature Methods.

[5]  Yamuna Krishnan,et al.  A DNA nanomachine that maps spatial and temporal pH changes inside living cells. , 2009, Nature nanotechnology.

[6]  Weihong Tan,et al.  Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics , 2013, Proceedings of the National Academy of Sciences.

[7]  S Moein Moghimi,et al.  A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  Daniel G. Anderson,et al.  Molecularly Self-Assembled Nucleic Acid Nanoparticles for Targeted In Vivo siRNA Delivery , 2012, Nature nanotechnology.

[9]  Pekka Orponen,et al.  DNA rendering of polyhedral meshes at the nanoscale , 2015, Nature.

[10]  P. Rothemund.  Folding DNA to create nanoscale shapes and patterns , 2006, Nature.

[11]  Ezequiel Bernabeu,et al.  The transferrin receptor and the targeted delivery of therapeutic agents against cancer. , 2012, Biochimica et biophysica acta.

[12]  D. Schaffert,et al.  Gene therapy progress and prospects: synthetic polymer-based systems , 2008, Gene Therapy.

[13]  Yamuna Krishnan,et al.  Two DNA nanomachines map pH changes along intersecting endocytic pathways inside the same cell. , 2013, Nature nanotechnology.

[14]  D. Meldrum,et al.  Stability of DNA origami nanoarrays in cell lysate. , 2011, Nano letters.

[15]  Andrew J Turberfield,et al.  Single-molecule protein encapsulation in a rigid DNA cage. , 2006, Angewandte Chemie.

[16]  Jie Chao,et al.  Structural DNA nanotechnology for intelligent drug delivery. , 2014, Small.

[17]  Shawn M. Douglas,et al.  A Logic-Gated Nanorobot for Targeted Transport of Molecular Payloads , 2012, Science.

[18]  Thomas Tørring,et al.  Template-directed covalent conjugation of DNA to native antibodies, transferrin and other metal-binding proteins. , 2014, Nature chemistry.

[19]  J. Reif,et al.  Logical computation using algorithmic self-assembly of DNA triple-crossover molecules , 2000, Nature.

[20]  Veikko Linko,et al.  DNA Nanostructures as Smart Drug-Delivery Vehicles and Molecular Devices. , 2015, Trends in biotechnology.

[21]  R. Klausner,et al.  Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Miller,et al.  An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery. , 1998, Human gene therapy.

[23]  J. Kjems,et al.  Enzymatic ligation of large biomolecules to DNA. , 2013, ACS nano.

[24]  J. Kjems,et al.  Quantification of cellular uptake of DNA nanostructures by qPCR. , 2014, Methods.

[25]  Richard A. Muscat,et al.  DNA nanotechnology from the test tube to the cell. , 2015, Nature nanotechnology.

[26]  Hongzhe Sun,et al.  Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.

[27]  William M. Shih,et al.  Addressing the Instability of DNA Nanostructures in Tissue Culture , 2014, ACS nano.

[28]  Björn Högberg,et al.  DNA origami delivery system for cancer therapy with tunable release properties. , 2012, ACS nano.

[29]  K. Mechtler,et al.  DNA-binding transferrin conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety. , 1991, Bioconjugate chemistry.

[30]  Antti-Pekka Eskelinen,et al.  Virus-encapsulated DNA origami nanostructures for cellular delivery. , 2014, Nano letters.

[31]  B. Sullenger,et al.  Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells. , 2012, Nucleic acid therapeutics.

[32]  Hao Yan,et al.  DNA origami as a carrier for circumvention of drug resistance. , 2012, Journal of the American Chemical Society.

[33]  Yamuna Krishnan,et al.  Designing DNA nanodevices for compatibility with the immune system of higher organisms. , 2015, Nature nanotechnology.

[34]  A. Takayanagi,et al.  A novel gene delivery system using EGF receptor‐mediated endocytosis , 1994, FEBS letters.

[35]  Thomas Tørring,et al.  Functional patterning of DNA origami by parallel enzymatic modification. , 2011, Bioconjugate chemistry.